Cargando…
Immune-Related Sclerosing Cholangitis and Subsequent Pyogenic Liver Abscesses in Two Patients With Melanoma Treated by Triplet Therapy: A Case Report
Immune checkpoint inhibitors have improved the treatment of many cancers. However, immune-related (IR) adverse events can limit their use. A rare but potentially severe IR adverse event is IR-cholangitis, which is mostly induced by anti-programmed cell death 1 (PD1) antibodies and is often corticost...
Autores principales: | Schön, Viola, Stocker, Daniel, Jüngst, Christoph, Dummer, Reinhard, Ramelyte, Egle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540752/ https://www.ncbi.nlm.nih.gov/pubmed/37728439 http://dx.doi.org/10.1097/CJI.0000000000000486 |
Ejemplares similares
-
The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
por: Dummer, Reinhard, et al.
Publicado: (2023) -
Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis
por: Ghafoor, Soleen, et al.
Publicado: (2022) -
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
Recurrent squamous cell carcinoma of the perianal skin: a case report
por: Staeger, Ramon, et al.
Publicado: (2020) -
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)